Undercover Sting Nails Unlicensed Miami Injector Using Unapproved Botox Alternative
MIAMI — A South Florida woman who allegedly presented herself as a medical professional on social media was arrested last month in an undercover sting operation, highlighting ongoing regulatory concerns in the burgeoning cosmetic injection industry.
Mayling Maya-Giraldo, 31, was taken into custody on February 19 at her studio after an undercover agent with the Florida Department of Health scheduled a Botox appointment via Instagram. According to court documents obtained by PEOPLE, Maya-Giraldo was charged with practicing healthcare without a license, possession of a drug with intent to sell, and misrepresenting a professional license. She has entered a written plea of not guilty.
The arrest affidavit details that Maya-Giraldo operated under the Instagram handle @mayling.stetic, using the title "doctor" in her profile biography. The account featured videos of her performing procedures like Botox, lip filler, and laser treatments.
The undercover agent, identified as a medical quality assurance investigator, paid $450 for the appointment. After applying a topical anesthetic, but before any injection was administered, detectives with the state's Medical Crimes Squad moved in. When questioned, Maya-Giraldo allegedly admitted she had no medical license but claimed to hold certificates for administering Botox.
Authorities say the vial seized at the scene contained "Toxta," a South Korean product similar to Botox that is not approved for use in the United States. The unregulated status of such drugs poses significant health risks, including potential contamination or incorrect dosing.
Maya-Giraldo was booked into Miami-Dade County Jail. Her arraignment is scheduled for April 20.
Industry Background & Impact: This case underscores the persistent challenge regulators face in policing the rapidly growing, social-media-driven market for non-surgical cosmetic procedures. While licensed medical practitioners must adhere to strict safety and hygiene standards, unlicensed operators often bypass these safeguards, putting clients at risk of infection, disfigurement, or worse from improperly administered substances.
Reactions & Commentary:
"This is a depressingly common story," said Dr. Alisha Chen, a board-certified dermatologist in Miami Beach. "Patients are lured by lower prices and slick social media marketing, not realizing they're gambling with their health. That 'Toxta' product has no FDA oversight—we have no idea what's really in it."
Marcus Reed, a clinic owner and licensed nurse injector, offered a different perspective: "Look, the demand is massive and the traditional medical model is expensive. This isn't black and white. While what she did was illegal, it also points to a system that makes proper training and licensing inaccessible for some."
"Are you kidding me? This is pure negligence," exclaimed Sarah Gibson, a patient advocate whose sister suffered complications from a botched filler treatment. "Calling yourself a 'doctor' online when you're not is fraud, period. These people are predators preying on insecurity, and the penalties need to be much harsher. It makes my blood boil."
David Park, a regulatory attorney specializing in healthcare, noted the legal stakes: "Beyond the criminal charges, she faces significant civil liability. Using an unapproved drug escalates this from a licensing violation to a serious federal issue. This arrest will likely trigger a broader probe into her supply chain."